AG NPP709 is currently available; even so, no study has investigated the result of AG NPP709 in patients with COPD. For that reason, the aim of this review was to evaluate the efficacy of AG NPP709 in patients with Long-term bronchitis kind COPD. Berberine suppresses inflammatory brokers-induced interleukin-1beta and https://andyq007plh3.blog2freedom.com/profile